Bavarian Nordic R/I ADR (OP:BVNRY)

12.28 UNCHANGED

Delayed Quote Updated: 3:50 PM EDT, Oct 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bavarian Nordic R/I ADR

< Previous 1 2 3 Next >

Experts Cast Doubt On Dependence On Monkeypox Vaccine Amid Limited Trial Data, Supply Crunch ↗

August 23, 2022

The only FDA-approved monkeypox vaccine from Bavarian Nordic A/S (OTC: BVNY) is in short supply.

Via Benzinga

Applied DNA Seeks Approval For PCR-Based Monkeypox Virus Test ↗

August 19, 2022

Via Benzinga

Bavarian Nordic Recruits US Firm For Packaging Services For Its Monkeypox Vaccine ↗

August 19, 2022

Via Benzinga

Biden Officials Seek To Boost Supply For Monkeypox Vaccines, Treatment ↗

August 18, 2022

Top Biden administration officials are poised to lay out new steps to accelerate the U.S. response amid the spread of monkeypox and demand for vaccines & treatments.

Via Benzinga

7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher ↗

August 17, 2022

These monkeypox stocks could be among the best choices to buy in August. Each can make great investments as government responses ramp up.

Via InvestorPlace

Bavarian Nordic's Monkeypox Vaccine Gets Thumbs Up From EU Regulator ↗

July 22, 2022

Via Benzinga

EU, Bavarian Nordic Ink Supply Pact For 110,000 Monkeypox Vaccines ↗

June 14, 2022

Via Benzinga

The Only Monkeypox Vaccine Maker Finds It Difficult To Meet Accelerating Demand ↗

August 17, 2022

Bavarian Nordic A/S (OTC: BVNKF), the only company with an approved vaccine for monkeypox, said it’s no longer sure it can meet demand as cases continue to rise worldwide,

Via Benzinga

Plan To Extend Supply Of Monkeypox Vaccine On Cusp Of Emergency Clearance: Report ↗

August 09, 2022

A plan to extend the limited supply of monkeypox vaccine in order to provide additional doses may soon be receiving emergency clearance by U.S. health officials.

Via Benzinga

3 Monkeypox Stocks to Buy as Biden Declares Public Health Emergency ↗

August 05, 2022

Monkeypox stocks are about to rise now that the White House has declared the virus a public health emergency. Here are the stocks to watch.

Via InvestorPlace

VRAX Stock Alert: Why Is Virax Biolabs Up 120% Today? ↗

August 01, 2022

With monkeypox infections rising, Virax Biolabs’ PCR test for the underlying virus is bolstering sentiment for VRAX stock.

Via InvestorPlace

Monkeypox Stocks On The Move: What Investors Should Know About The Outbreak ↗

August 01, 2022

The World Health Organization has declared the 2022 outbreak of monkeypox a global health emergency. The monkeypox crisis isn't as severe as the COVID-19 pandemic, but it has a number of health care...

Via Benzinga

Why Is SIGA Technologies (SIGA) Stock Plunging 23% Today? ↗

July 29, 2022

SIGA stock is sinking lower after the FDA released a report, stating that TPOXX has not demonstrated efficacy in humans against monkeypox.

Via InvestorPlace

Monkeypox Stocks SIGA, GOVX, BVNRY, CHMX, EBS Soar on Global Health Emergency ↗

July 25, 2022

Drugs and vaccines used against smallpox are seen as the first line of defense against the rising tide of monkeypox infections.

Via InvestorPlace

SIGA Stock Soars as WHO Declares Monkeypox Global Health Emergency ↗

July 25, 2022

It's not every day that SIGA stock trends in the financial media, but today vaccine stocks are in focus due to the spread of monkeypox.

Via InvestorPlace

Bavarian Nordic's Monkeypox Vaccine Scores EU Approval As WHO Declares Global Health Emergency ↗

July 25, 2022

Via Benzinga

Benzinga Before The Bell: Snap's Dismal Earnings, Amazon's Healthcare Foray, Robinhood Moves 41B Dogecoin Into Single Wallet And Other Top Financial Stories Friday, July 22 ↗

July 22, 2022

Reuters

Via Benzinga

The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings ↗

July 19, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine ↗

July 18, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Bavarian Nordic Inks Multiple Supply Pact For Its Monkey pox Vaccine, Updates FY22 Guidance ↗

July 18, 2022

Via Benzinga

Lawmaker Warns San Francisco Faces 'Public Health Mess' Over Monkeypox Vaccine Shortage ↗

July 14, 2022

A California state legislator representing the Bay Area declared San Francisco is "veering toward a public health mess" after the city’s Department of Public Health acknowledged it is running out of...

Via Benzinga

Quest Diagnostics Unveils Monkeypox Test: What You Need To Know ↗

July 13, 2022

Quest Diagnostics (NYSE: DGX) has announced the nationwide availability of a lab-developed, automated molecular diagnostic test to identify if a person is infected with monkeypox.

Via Benzinga

20% Of US Monkeypox Cases Are In This City ↗

July 08, 2022

New York City has become the monkeypox capital of the U.S., with nearly 20% of the nation’s reported cases. What Happened: According to the New York Post, the city recorded 119 cases as of Wednesday....

Via Benzinga

Monkeypox Stocks BVNRY, EBS, CMRX, SIGA Heat Up on U.S. Vaccine Stockpile ↗

June 29, 2022

Pharmaceutical companies that make vaccines against monkeypox are getting attention as demand for treatments against the virus grow.

Via InvestorPlace

White House Outlines New Monkeypox Vaccine Strategy: What You Need To Know ↗

June 29, 2022

Via Benzinga

Bavarian Nordic Launches COVID-19 Booster Study To Compare Against Pfizer/BioNTech Shot ↗

June 16, 2022

Via Benzinga

Morning Brief: Top Financial Stories Dominating on Tuesday, June 14 ↗

June 14, 2022

CNBC

Via Benzinga

7 Monkeypox Stocks That May Take Off in Q2 ↗

June 09, 2022

SIGA Technologies (SIGA) may lead on the list of Monkeypox stocks that could soar, but Bavarian Nordic seems to be leading the sales race.

Via InvestorPlace

Why Is AIkido Pharma (AIKI) Stock Up 1,400%? ↗

June 07, 2022

AIkido Pharma (AIKI) stock is skyrocketing on Tuesday but it's not due to any positive news from the biotechnology company.

Via InvestorPlace

Bavarian Nordic (BVNRY) Stock Gets a Boost From New Canadian Contract ↗

June 07, 2022

Bavarian Nordic (BVNRY) stock is rising higher on Tuesday after announcing a new deal with Canada to purchase one of its vaccines.

Via InvestorPlace

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.